| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.002 |